Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Long Beach › NPI 1043384829
Physician

Luke R Watson MD INC

Luke R Watson MD INC was paid $1.42M by Medicaid between Jan 2018 and Dec 2024, across 118 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 16% of everything it billed.

33Billing provider infoLUKE R WATSON MD INC
LONG BEACH, CA 90806
33aNPI1043384829assigned 11/20/2006
28Total paid$1.42M
24GClaims847,524
24DCodes billed118
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in California

Rank by total paid#31 of 222
Median peer was paid$42K
This provider vs. median33×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018118,321$164K
2019165,669$248K
2020102,070$171K
2021128,261$209K
2022122,446$220K
2023141,293$290K
2024incomplete69,464$114K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
88305 Level IV - Surgical pathology, gross and microscopic examination 16% 7,744 6,674 $230K
80053 Comprehensive metabolic panel 12% 104,906 67,710 $175K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 10% 143,502 81,338 $145K
88312 5.9% 3,552 3,059 $84K
80048 Basic metabolic panel (calcium, ionized) 5.0% 53,635 27,535 $71K
88307 3.5% 1,071 1,061 $49K
88304 3.2% 3,057 2,965 $46K
84484 3.2% 33,130 26,096 $45K
82962 2.4% 11,792 3,810 $34K
87040 2.3% 13,800 12,205 $32K
82948 2.2% 36,708 12,251 $32K
84443 Thyroid stimulating hormone (TSH) 1.8% 13,233 11,856 $26K
106 more codes
83690 1.8% 30,561 $25K
83735 1.6% 22,956 $23K
85730 1.5% 24,917 $21K
83605 1.5% 14,334 $21K
83880 1.2% 4,833 $17K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.2% 2,829 $17K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.1% 3,267 $15K
85610 1.1% 27,314 $15K
83036 Hemoglobin; glycosylated (A1C) <1% 10,564 $13K
85060 <1% 1,467 $13K
81003 <1% 32,224 $12K
87086 Culture, bacterial; quantitative colony count, urine <1% 12,196 $11K
86920 <1% 1,497 $11K
87077 <1% 7,707 $10K
84100 <1% 15,984 $10K
80061 Lipid panel <1% 5,615 $10K
88341 <1% 166 $10K
88342 <1% 326 $9K
81001 <1% 18,825 $9K
83020 <1% 5,370 $8K
87186 <1% 6,294 $8K
81025 <1% 12,581 $8K
87631 <1% 1,211 $8K
85027 <1% 9,099 $7K
83718 <1% 7,494 $7K
80320 <1% 6,892 $7K
80305 <1% 4,001 $6K
82140 <1% 3,285 $6K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 332 $6K
80202 <1% 2,954 $5K
82465 <1% 8,726 $5K
82550 <1% 6,198 $5K
85007 <1% 11,551 $5K
84145 <1% 1,525 $5K
83520 <1% 2,624 $5K
82553 <1% 2,934 $5K
84702 <1% 3,765 $5K
84478 <1% 9,246 $5K
87081 <1% 3,887 $3K
86592 <1% 5,795 $3K
80074 <1% 473 $3K
80076 <1% 3,909 $3K
86901 <1% 8,273 $3K
84703 <1% 4,653 $3K
88112 <1% 120 $3K
80164 <1% 1,371 $2K
86900 <1% 5,928 $2K
86850 <1% 5,027 $2K
82746 <1% 983 $2K
87071 <1% 2,400 $2K
87070 <1% 1,582 $2K
81015 <1% 5,445 $2K
83540 <1% 1,508 $1K
82728 <1% 865 $1K
82607 <1% 709 $1K
88302 <1% 82 $1K
81005 <1% 3,114 $1K
87430 <1% 1,244 $1K
82150 <1% 1,203 $949.84
86703 <1% 515 $916.28
88311 <1% 248 $913.99
85379 <1% 805 $912.08
84466 <1% 604 $899.85
82803 <1% 427 $872.37
87340 <1% 694 $796.93
85378 <1% 702 $782.31
84439 <1% 791 $774.40
87400 <1% 1,182 $755.12
85009 <1% 1,352 $700.76
83615 <1% 958 $590.25
82565 <1% 1,039 $563.84
87205 <1% 1,058 $530.29
85651 <1% 1,178 $476.28
82270 <1% 1,062 $467.39
82009 <1% 699 $439.66
80329 <1% 792 $420.86
80185 <1% 246 $349.89
82570 <1% 370 $317.52
86803 <1% 160 $271.05
85014 <1% 554 $261.10
85018 <1% 667 $240.41
84134 <1% 114 $207.44
88108 <1% 15 $206.89
84300 <1% 304 $193.58
86709 <1% 132 $178.90
86705 <1% 131 $178.60
86593 <1% 373 $162.32
84550 <1% 343 $151.19
86880 <1% 213 $122.93
86922 <1% 19 $118.19
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 29 $106.32
85008 <1% 673 $102.62
82977 <1% 113 $96.58
86769 <1% 14 $92.00
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 26 $86.25
80047 <1% 36 $70.82
87073 <1% 69 $59.93
82248 <1% 113 $53.57
85044 <1% 83 $49.23
86141 <1% 26 $39.76
83550 <1% 31 $35.49
82947 <1% 59 $30.59
84132 <1% 68 $23.82
80178 <1% 18 $15.01
82247 <1% 39 $13.64
85384 <1% 15 $12.98

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWATSON, LUKE (MED DIRECTOR)